Skip to main content

Table 2 Study cohort

From: Anaphylactic reactions in the build-up phase of rush immunotherapy for bee venom allergy in pediatric patients: a single-center experience

Variable

N

(%)

No. of patients

19

 

Age in years

 Median

9

 

 Minimum

4

 

 Maximum

14

 

Pre-existing conditions

4

(21.1%)

 Other allergies

1

 

 Autoimmune

2

 

 Hematological

1

 

Grade of anaphylactic reaction to initial field sting

 Grade I

3

 

 Grade II

8

 

 Grade III

8

 

 Grade IV

0

 

Anaphylactic reaction to rush immunotherapy

3

(15.8%)

 Grade I

1

 

 Grade II

2

 

 Grade III

0

 

 Grade IV

0